Share on StockTwits

Dentsply International Inc. (NASDAQ:XRAY) updated its FY14 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $2.47-2.55 for the period, compared to the Thomson Reuters consensus estimate of $2.52, Analyst Ratings Network.com reports.

A number of research firms have recently commented on XRAY. Analysts at Barrington Research upgraded shares of Dentsply International from a market perform rating to an outperform rating in a research note on Friday, May 16th. Analysts at Zacks reiterated a neutral rating on shares of Dentsply International in a research note on Wednesday, May 7th. They now have a $48.00 price target on the stock. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Dentsply International has an average rating of Buy and an average price target of $50.75.

Dentsply International Inc. (NASDAQ:XRAY) opened at 46.845 on Thursday. Dentsply International Inc. has a 1-year low of $41.31 and a 1-year high of $50.99. The stock has a 50-day moving average of $47.43 and a 200-day moving average of $46.42. The company has a market cap of $6.642 billion and a price-to-earnings ratio of 21.86.

Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, July 31st. The company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.01. The company had revenue of $765.20 million for the quarter, compared to the consensus estimate of $782.86 million. During the same quarter in the previous year, the company posted $0.66 earnings per share. The company’s revenue for the quarter was up .6% on a year-over-year basis. Analysts expect that Dentsply International Inc. will post $2.52 EPS for the current fiscal year.

DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.